European Headache Federation
@ehfofficial.bsky.social
Improving awareness of headache disorders and their impact across Europe. Official journal: Journal of Headache and Pain
Growing evidence shows that sleep disruption is a feature of primary headache disorders.
A new systematic review found reduced sleep efficiency, increased night-time awakenings, and altered arousal patterns in migraine, with emerging similarities in cluster headache.
Read: doi.org/10.1186/s101...
A new systematic review found reduced sleep efficiency, increased night-time awakenings, and altered arousal patterns in migraine, with emerging similarities in cluster headache.
Read: doi.org/10.1186/s101...
February 5, 2026 at 8:13 AM
Growing evidence shows that sleep disruption is a feature of primary headache disorders.
A new systematic review found reduced sleep efficiency, increased night-time awakenings, and altered arousal patterns in migraine, with emerging similarities in cluster headache.
Read: doi.org/10.1186/s101...
A new systematic review found reduced sleep efficiency, increased night-time awakenings, and altered arousal patterns in migraine, with emerging similarities in cluster headache.
Read: doi.org/10.1186/s101...
New real-world data show effectiveness of eptinezumab in difficult-to-treat migraine patients.
In a multi-centre study, ~70% of patients achieved a ≥50% reduction in migraine days within 6 months, with major improvements in disability and quality of life.
Read more: doi.org/10.1186/s101...
In a multi-centre study, ~70% of patients achieved a ≥50% reduction in migraine days within 6 months, with major improvements in disability and quality of life.
Read more: doi.org/10.1186/s101...
February 4, 2026 at 7:45 AM
New real-world data show effectiveness of eptinezumab in difficult-to-treat migraine patients.
In a multi-centre study, ~70% of patients achieved a ≥50% reduction in migraine days within 6 months, with major improvements in disability and quality of life.
Read more: doi.org/10.1186/s101...
In a multi-centre study, ~70% of patients achieved a ≥50% reduction in migraine days within 6 months, with major improvements in disability and quality of life.
Read more: doi.org/10.1186/s101...
New preclinical evidence strengthens the link between CGRP and migraine-associated photophobia.
CGRP induced light avoidance and headache-like pain in rats, closely mirroring human migraine provocation studies, offering strong translational relevance for studying migraine.
doi.org/10.1186/s101...
CGRP induced light avoidance and headache-like pain in rats, closely mirroring human migraine provocation studies, offering strong translational relevance for studying migraine.
doi.org/10.1186/s101...
February 2, 2026 at 7:42 AM
New preclinical evidence strengthens the link between CGRP and migraine-associated photophobia.
CGRP induced light avoidance and headache-like pain in rats, closely mirroring human migraine provocation studies, offering strong translational relevance for studying migraine.
doi.org/10.1186/s101...
CGRP induced light avoidance and headache-like pain in rats, closely mirroring human migraine provocation studies, offering strong translational relevance for studying migraine.
doi.org/10.1186/s101...
In a collaboration with Headache, Cephalalgia has published a series of 2025 highlights reflecting on a year of milestones across migraine and headache research.
These highlights cutting-edge work in headache medicine. Read from the collection here: journals.sagepub.com/doi/full/10....
These highlights cutting-edge work in headache medicine. Read from the collection here: journals.sagepub.com/doi/full/10....
January 30, 2026 at 8:26 PM
In a collaboration with Headache, Cephalalgia has published a series of 2025 highlights reflecting on a year of milestones across migraine and headache research.
These highlights cutting-edge work in headache medicine. Read from the collection here: journals.sagepub.com/doi/full/10....
These highlights cutting-edge work in headache medicine. Read from the collection here: journals.sagepub.com/doi/full/10....
This latest study reports the real-world data on medication-overuse headache from Egypt.
A preventable cause of chronic headache with major impact on patients’ lives, especially in low- and middle-income settings:
Read more: lnkd.in/eVWzaWja
#Migraine #JournalOfHeadacheAndPain #MedicationOveruse
A preventable cause of chronic headache with major impact on patients’ lives, especially in low- and middle-income settings:
Read more: lnkd.in/eVWzaWja
#Migraine #JournalOfHeadacheAndPain #MedicationOveruse
January 28, 2026 at 7:47 AM
This latest study reports the real-world data on medication-overuse headache from Egypt.
A preventable cause of chronic headache with major impact on patients’ lives, especially in low- and middle-income settings:
Read more: lnkd.in/eVWzaWja
#Migraine #JournalOfHeadacheAndPain #MedicationOveruse
A preventable cause of chronic headache with major impact on patients’ lives, especially in low- and middle-income settings:
Read more: lnkd.in/eVWzaWja
#Migraine #JournalOfHeadacheAndPain #MedicationOveruse
A recent study introduces the “four dimensions (4D) migraine scale,” a composite tool that integrates key clinical and patient-centered features to better quantify migraine severity and treatment response.
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
January 26, 2026 at 9:19 PM
A recent study introduces the “four dimensions (4D) migraine scale,” a composite tool that integrates key clinical and patient-centered features to better quantify migraine severity and treatment response.
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
A new systematic review and meta-analysis from researchers on behalf of the European Headache Federation (EHF)—evaluates long-term (≥12 months) safety of monoclonal antibodies targeting the CGRP pathway for migraine prevention.
doi.org/10.1186/s101...
doi.org/10.1186/s101...
January 26, 2026 at 9:16 PM
A new systematic review and meta-analysis from researchers on behalf of the European Headache Federation (EHF)—evaluates long-term (≥12 months) safety of monoclonal antibodies targeting the CGRP pathway for migraine prevention.
doi.org/10.1186/s101...
doi.org/10.1186/s101...
A comparative 7 T multimodal MRI study shows that migraine with aura is associated with distinct subcortical nuclei alterations and glymphatic dysfunction compared to migraine without aura and healthy controls.
👉 doi.org/10.1186/s101...
👉 doi.org/10.1186/s101...
January 24, 2026 at 11:40 AM
A comparative 7 T multimodal MRI study shows that migraine with aura is associated with distinct subcortical nuclei alterations and glymphatic dysfunction compared to migraine without aura and healthy controls.
👉 doi.org/10.1186/s101...
👉 doi.org/10.1186/s101...
A randomized, placebo-controlled crossover study found that sildenafil reliably induced headache but not migraine-like attacks in men with migraine without aura, contrasting with higher migraine induction in women.
doi.org/10.1186/s101...
doi.org/10.1186/s101...
January 24, 2026 at 10:43 AM
A randomized, placebo-controlled crossover study found that sildenafil reliably induced headache but not migraine-like attacks in men with migraine without aura, contrasting with higher migraine induction in women.
doi.org/10.1186/s101...
doi.org/10.1186/s101...
New research shows that spreading depolarizations can activate the cGAS–STING immune pathway, fueling inflammation and head pain linked to migraine with aura.
The study also found that targeting this pathway may reduce pain responses in preclinical models.
doi.org/10.1186/s101...
The study also found that targeting this pathway may reduce pain responses in preclinical models.
doi.org/10.1186/s101...
January 23, 2026 at 7:41 PM
New research shows that spreading depolarizations can activate the cGAS–STING immune pathway, fueling inflammation and head pain linked to migraine with aura.
The study also found that targeting this pathway may reduce pain responses in preclinical models.
doi.org/10.1186/s101...
The study also found that targeting this pathway may reduce pain responses in preclinical models.
doi.org/10.1186/s101...
The Journal of Headache and Pain is now accepting submissions for the 2026 Early Career Research Mentorship Program.
🧠 PhD, Postdocs & Residents
📝 Original Research or Review
🏆 10 APC waivers
✨ Opportunity to join the Junior Editorial Board
⏰ Deadline: 31 Aug 2026 (or until awards allocated)
🧠 PhD, Postdocs & Residents
📝 Original Research or Review
🏆 10 APC waivers
✨ Opportunity to join the Junior Editorial Board
⏰ Deadline: 31 Aug 2026 (or until awards allocated)
December 16, 2025 at 12:17 PM
The Journal of Headache and Pain is now accepting submissions for the 2026 Early Career Research Mentorship Program.
🧠 PhD, Postdocs & Residents
📝 Original Research or Review
🏆 10 APC waivers
✨ Opportunity to join the Junior Editorial Board
⏰ Deadline: 31 Aug 2026 (or until awards allocated)
🧠 PhD, Postdocs & Residents
📝 Original Research or Review
🏆 10 APC waivers
✨ Opportunity to join the Junior Editorial Board
⏰ Deadline: 31 Aug 2026 (or until awards allocated)
Thanks to everyone who joined us at the European Headache Congress 2025. Your support made the meeting unforgettable.
📸 Got photos? Tag us! We’d love to see your moments from the congress.
🌍 Planning ahead—2026 details coming soon. Keep an eye on our social channels and the website for updates.
📸 Got photos? Tag us! We’d love to see your moments from the congress.
🌍 Planning ahead—2026 details coming soon. Keep an eye on our social channels and the website for updates.
December 11, 2025 at 1:26 PM
Thanks to everyone who joined us at the European Headache Congress 2025. Your support made the meeting unforgettable.
📸 Got photos? Tag us! We’d love to see your moments from the congress.
🌍 Planning ahead—2026 details coming soon. Keep an eye on our social channels and the website for updates.
📸 Got photos? Tag us! We’d love to see your moments from the congress.
🌍 Planning ahead—2026 details coming soon. Keep an eye on our social channels and the website for updates.
The EHF School of Advanced Studies (SAS) meet at the Congress in Lisbon! 🧠✨
The SAS offers high-level training for early-career clinicians & researchers to deepen their expertise in migraine and headache medicine.
Want to join the 2026 cohort? Keep an eye on the EHF website for updates.
The SAS offers high-level training for early-career clinicians & researchers to deepen their expertise in migraine and headache medicine.
Want to join the 2026 cohort? Keep an eye on the EHF website for updates.
December 10, 2025 at 12:17 PM
The EHF School of Advanced Studies (SAS) meet at the Congress in Lisbon! 🧠✨
The SAS offers high-level training for early-career clinicians & researchers to deepen their expertise in migraine and headache medicine.
Want to join the 2026 cohort? Keep an eye on the EHF website for updates.
The SAS offers high-level training for early-career clinicians & researchers to deepen their expertise in migraine and headache medicine.
Want to join the 2026 cohort? Keep an eye on the EHF website for updates.
Exciting news from the European Headache Congress in Lisbon! 🎉
Congrats to the newly elected European Headache Federation board members:
🇳🇱 Rolf Fronczek
🇹🇷 Esme Ekizoglu
🇷🇸 Igor Petrusic
#EHC2025 #EHF #Neurology
Congrats to the newly elected European Headache Federation board members:
🇳🇱 Rolf Fronczek
🇹🇷 Esme Ekizoglu
🇷🇸 Igor Petrusic
#EHC2025 #EHF #Neurology
December 9, 2025 at 10:17 PM
Exciting news from the European Headache Congress in Lisbon! 🎉
Congrats to the newly elected European Headache Federation board members:
🇳🇱 Rolf Fronczek
🇹🇷 Esme Ekizoglu
🇷🇸 Igor Petrusic
#EHC2025 #EHF #Neurology
Congrats to the newly elected European Headache Federation board members:
🇳🇱 Rolf Fronczek
🇹🇷 Esme Ekizoglu
🇷🇸 Igor Petrusic
#EHC2025 #EHF #Neurology
📣 EHC 2025 Closing Ceremony!
We are thrilled to announce that the European Headache Congress (EHC 2026) will be held in the magnificent city of Berlin (9-12 December 2026)
Save the date! We can’t wait to see you there!
#EHC2025 #Lisbon #ClosingCeremony #EHC2026 #Berlin #HeadacheCongress
We are thrilled to announce that the European Headache Congress (EHC 2026) will be held in the magnificent city of Berlin (9-12 December 2026)
Save the date! We can’t wait to see you there!
#EHC2025 #Lisbon #ClosingCeremony #EHC2026 #Berlin #HeadacheCongress
December 7, 2025 at 12:20 PM
📣 EHC 2025 Closing Ceremony!
We are thrilled to announce that the European Headache Congress (EHC 2026) will be held in the magnificent city of Berlin (9-12 December 2026)
Save the date! We can’t wait to see you there!
#EHC2025 #Lisbon #ClosingCeremony #EHC2026 #Berlin #HeadacheCongress
We are thrilled to announce that the European Headache Congress (EHC 2026) will be held in the magnificent city of Berlin (9-12 December 2026)
Save the date! We can’t wait to see you there!
#EHC2025 #Lisbon #ClosingCeremony #EHC2026 #Berlin #HeadacheCongress
Day 4: don't miss the session on Headache and Stroke, covering critical topics like Intracranial Hypertension and Cerebral Venous Thrombosis.
#EHC2025 #Headache #Stroke #Neurology
Follow us also on Instagram
www.instagram.com/european_hea...
#EHC2025 #Headache #Stroke #Neurology
Follow us also on Instagram
www.instagram.com/european_hea...
December 6, 2025 at 9:01 AM
Day 4: don't miss the session on Headache and Stroke, covering critical topics like Intracranial Hypertension and Cerebral Venous Thrombosis.
#EHC2025 #Headache #Stroke #Neurology
Follow us also on Instagram
www.instagram.com/european_hea...
#EHC2025 #Headache #Stroke #Neurology
Follow us also on Instagram
www.instagram.com/european_hea...
Join this afternoon at the European Headache Congress in Lisbon!
4pm in the Plenary Hall the European Headache Federation Award session.
17.15-18.45 the parallel sessions: Assessing outcomes in Headache Care and Basic Science of Headache.
Or browse the ePosters.
headache-congress.org #EHC2025
4pm in the Plenary Hall the European Headache Federation Award session.
17.15-18.45 the parallel sessions: Assessing outcomes in Headache Care and Basic Science of Headache.
Or browse the ePosters.
headache-congress.org #EHC2025
December 4, 2025 at 1:22 PM
Join this afternoon at the European Headache Congress in Lisbon!
4pm in the Plenary Hall the European Headache Federation Award session.
17.15-18.45 the parallel sessions: Assessing outcomes in Headache Care and Basic Science of Headache.
Or browse the ePosters.
headache-congress.org #EHC2025
4pm in the Plenary Hall the European Headache Federation Award session.
17.15-18.45 the parallel sessions: Assessing outcomes in Headache Care and Basic Science of Headache.
Or browse the ePosters.
headache-congress.org #EHC2025
Starting NOW: Plenary Session 3 at EHC 2025! Focus is on Neurodegeneration in Chronic Migraine and new findings on Neuropeptides in TACs. Essential translational science!
#EHC2025 #TranslationalViews #MigraineResearch
#EHC2025 #TranslationalViews #MigraineResearch
December 4, 2025 at 11:46 AM
Starting NOW: Plenary Session 3 at EHC 2025! Focus is on Neurodegeneration in Chronic Migraine and new findings on Neuropeptides in TACs. Essential translational science!
#EHC2025 #TranslationalViews #MigraineResearch
#EHC2025 #TranslationalViews #MigraineResearch
☀️ EHC 2025 Day 2: The Debate Heats Up!
The second day of EHC 2025 is starting strong with a lively debate in the Future Headache Experts (FHE) session! 🔥
#EHC2025 #FHE #FutureHeadacheExperts #Comorbidities
The second day of EHC 2025 is starting strong with a lively debate in the Future Headache Experts (FHE) session! 🔥
#EHC2025 #FHE #FutureHeadacheExperts #Comorbidities
December 4, 2025 at 10:15 AM
☀️ EHC 2025 Day 2: The Debate Heats Up!
The second day of EHC 2025 is starting strong with a lively debate in the Future Headache Experts (FHE) session! 🔥
#EHC2025 #FHE #FutureHeadacheExperts #Comorbidities
The second day of EHC 2025 is starting strong with a lively debate in the Future Headache Experts (FHE) session! 🔥
#EHC2025 #FHE #FutureHeadacheExperts #Comorbidities
🥂 EHC 2025 Day 1:
Day 1 is officially wrapped, highlighted by our inspiring Opening Ceremony.
The evening culminated in the presentation of the Lifetime Achievement Award to Professor Steiner.
We thank all attendees for making today unforgettable. See you tomorrow!
#EHC2025 #OpeningCeremony
Day 1 is officially wrapped, highlighted by our inspiring Opening Ceremony.
The evening culminated in the presentation of the Lifetime Achievement Award to Professor Steiner.
We thank all attendees for making today unforgettable. See you tomorrow!
#EHC2025 #OpeningCeremony
December 4, 2025 at 1:48 AM
🥂 EHC 2025 Day 1:
Day 1 is officially wrapped, highlighted by our inspiring Opening Ceremony.
The evening culminated in the presentation of the Lifetime Achievement Award to Professor Steiner.
We thank all attendees for making today unforgettable. See you tomorrow!
#EHC2025 #OpeningCeremony
Day 1 is officially wrapped, highlighted by our inspiring Opening Ceremony.
The evening culminated in the presentation of the Lifetime Achievement Award to Professor Steiner.
We thank all attendees for making today unforgettable. See you tomorrow!
#EHC2025 #OpeningCeremony
⚡️ NOW LIVE: Parallel Session 1!
Tune in right now for Parallel Session 1: Headache and Hormones
Tune in right now for Parallel Session 1: Headache and Hormones
December 3, 2025 at 12:11 PM
⚡️ NOW LIVE: Parallel Session 1!
Tune in right now for Parallel Session 1: Headache and Hormones
Tune in right now for Parallel Session 1: Headache and Hormones
Migraine and pregnancy-related headaches are independent risk factors for serious complications, including a significantly increased risk of stroke and other cardiovascular events during pregnancy and the postpartum period.
Full details: doi.org/10.1186/s101...
Full details: doi.org/10.1186/s101...
November 23, 2025 at 10:25 PM
Migraine and pregnancy-related headaches are independent risk factors for serious complications, including a significantly increased risk of stroke and other cardiovascular events during pregnancy and the postpartum period.
Full details: doi.org/10.1186/s101...
Full details: doi.org/10.1186/s101...